Litigators of the Week: A $406.8M Win for Regeneron in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen
law.com
•
Law
•
World
A Delaware jury awarded Regeneron $406.8 million in its antitrust lawsuit against Amgen, alleging Amgen illegally bundled its cholesterol drug with others to exclude Regeneron's competitor.